In 2020, Square Medical Group partnered with McLean Hospital/Harvard Medical School and other community treatment programs across the New England Consortium Node of the National Institutes of Health Clinical Trials Network. These studies not only afford us the professional and intellectual fulfillment of working with the nation’s best academic researchers, but also allow us to provide no cost, cutting-edge treatment to our patients. If you are interested in learning more about research at Square Medical Group.
Research
Current Research Projects at Square Medical Group
CTN-0100 RDD Study
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy
Now enrolling!
What is the purpose of this study?
To test treatment approaches, including medications, to help patients with opioid use disorder.
Am I eligible?
You may be eligible if you:
-
Have Opioid Use Disorder (OUD)
-
Are at least 18 years old
-
What is involved?
-
1 Screening visit
-
24 in-person (or telehealth) visits (over 1.5 years)
-
Medication for OUD
-
Medical Management visits
-
-
3 Follow-Up Visits (over 0.5 years)
Will I be compensated?
Yes. You may earn up to $760 for completing all study-related visits.
How much does it cost?
There is no charge to you for participating in this study.
For more information, visit: https://clinicaltrials.gov/ct2/show/NCT04464980
This study is recruiting from the community as well as the Square Medical Group MAT Program. If you have any questions or want to learn more, contact the study coordinator at RDD@partners.org or call 617-610-2169.